BPC-157 & TB-500 BPC-157 & TB-500 PRODUCT IMAGE
HPLC VERIFIED COA SUPPLIED ≥98.5% PURITY
— Healing & Repair

BPC-157 & TB-500 Dual-Action Healing & Repair Blend

For in vitro research use only. BPC-157 & TB-500 is not for human or veterinary consumption, diagnosis, treatment, or prevention of any condition.

A single vial containing 10mg of BPC-157 and 10mg of TB-500 — two of the most widely studied tissue-repair peptides in preclinical research. Combining them in one vial means researchers only need to reconstitute (dissolve and prepare) the compound once to work with both together.

CAS Number
137525-51-0 / 77591-33-4
Molecular Formula
BPC-157 (C₆₂H₉₈N₁₆O₂₂) + TB-500 fragment
HPLC Purity
98.5% (batch-verified)
Form
Lyophilised powder
Storage
2–8°C, desiccated, protected from light
Classification
Research reagent — in vitro use only

Research overview

This vial contains 10mg of BPC-157 and 10mg of TB-500 combined — two widely studied peptides (short chains of amino acids) that appear frequently in tissue-repair research. BPC-157 (Body Protection Compound-157) is a 15-amino-acid synthetic peptide. Rodent studies have looked into its effects on angiogenesis (new blood vessel growth), wound closure, and gut lining protection. TB-500 is a synthetic version of a small part of a protein called Thymosin Beta-4. Preclinical studies have investigated its role in regulating actin (a structural protein that controls how cells move), and how cells migrate to sites of tissue damage. Combining both in one vial simplifies research protocols where both are needed together. Supplied as a single 20mg co-lyophilised (freeze-dried) vial, with 10mg of each compound. For research use only. Not for human or veterinary consumption.

Summary paraphrased from the peer-reviewed preclinical literature. Full citations will be available in the research library. For in vitro research use only.

Compound specifications

Common nameBPC-157 & TB-500
Full nameDual-Action Healing & Repair Blend
CAS number137525-51-0 / 77591-33-4
Molecular formulaBPC-157 (C₆₂H₉₈N₁₆O₂₂) + TB-500 fragment
Molecular weight1419.5 + 4963.4 g/mol
SequenceGEPPPGKPADDAGLV (BPC-157) + Ac-SD...Ac-SDKPDMAEIEKFDKS-fragment (TB-500)
HPLC purity98.5% (batch-verified)
AppearanceWhite to off-white lyophilised powder
SolubilityBacteriostatic water, sterile saline
Storage (lyophilised)2–8°C, protected from light
Storage (reconstituted)2–8°C, up to 28 days
Supplied as20mg (10mg BPC-157 + 10mg TB-500)

Batch testing and certificate of analysis

Every batch of BPC-157 & TB-500 is third-party HPLC-tested prior to dispatch. A batch-specific certificate of analysis documenting HPLC purity, mass spectrometry confirmation, and appearance is supplied with every order.

Previous batch CoAs are archived in the CoA library. For batch-specific CoA requests prior to purchase, contact veloxpeps@gmail.com.

Frequently Asked Research-Use Questions

What is in the BPC-157 & TB-500 vial?
Each vial contains 10mg of BPC-157 (Body Protection Compound-157) and 10mg of TB-500 (synthetic thymosin beta-4 fragment), co-lyophilised in a single sterile vial — 20mg total peptide content.
What purity is the BPC-157 & TB-500?
The BPC-157 & TB-500 is supplied at 98.5% HPLC-verified purity for both components. A batch-specific certificate of analysis documenting purity, mass spectrometry confirmation, and appearance is provided with every order.
How is the BPC-157 & TB-500 reconstituted for research use?
The mix is supplied as a co-lyophilised powder in a single sterile vial. For in vitro research use, reconstitution is performed with bacteriostatic water. See the reconstitution calculator for volume calculations based on your required concentration.
What is the difference between the BPC-157 & TB-500 and the BPC-157 + TB-500 Bundle?
The Mix supplies both compounds co-lyophilised together in a single 20mg vial — one reconstitution step for both. The Bundle supplies BPC-157 and TB-500 as two separate individual vials (10mg each), allowing independent dosing and reconstitution of each compound. The Mix suits protocols where both compounds are always used together; the Bundle offers greater flexibility.

For in vitro research use only. BPC-157 & TB-500 is supplied solely as a research reagent for qualified professionals conducting in vitro or animal-model studies. It is not a medicinal product within the meaning of the Human Medicines Regulations 2012. It has not been evaluated by the MHRA or FDA. It is not intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale.

Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.